Global Transdermal Patch Market Growth 2020-2025
According to this study, over the next five years the Transdermal Patch market will register a 3.7%% CAGR in terms of revenue, the global market size will reach $ 7628.3 million by 2025, from $ 6598.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Transdermal Patch business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Patch market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Transdermal Patch, covering the supply chain analysis, impact assessment to the Transdermal Patch market size growth rate in several scenarios, and the measures to be undertaken by Transdermal Patch companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Methyl Salicylate-Based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Rx Channel
OTC Channel
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Hisamitsu Pharmaceutical
GSK
Johnson & Johnson
UCB Pharma
Mylan
Novartis
Grünenthal
Teva Pharmaceutical
IBSA Group
Nitto Denko
Mundipharma
Beijing Tide Pharmaceutical
Endo International
Luye Pharma Group
Dr Reddy's Laboratories
Chattem
Bayer
Pfizer
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Transdermal Patch consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Transdermal Patch market by identifying its various subsegments.
Focuses on the key global Transdermal Patch manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Transdermal Patch with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Transdermal Patch submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transdermal Patch Consumption 2015-2025
2.1.2 Transdermal Patch Consumption CAGR by Region
2.2 Transdermal Patch Segment by Type
2.2.1 Methyl Salicylate-Based Patch
2.2.2 Rivastigmine Transdermal Patch
2.2.3 Fentanyl Transdermal Patch
2.2.4 Lidocaine Patch
2.2.5 Diclofenac Patch
2.2.6 Nicotine Transdermal Patch
2.2.7 Others
2.3 Transdermal Patch Consumption by Type
2.3.1 Global Transdermal Patch Consumption Market Share by Type (2015-2020)
2.3.2 Global Transdermal Patch Revenue and Market Share by Type (2015-2020)
2.3.3 Global Transdermal Patch Sale Price by Type (2015-2020)
2.4 Transdermal Patch Segment by Application
2.4.1 Rx Channel
2.4.2 OTC Channel
2.5 Transdermal Patch Consumption by Application
2.5.1 Global Transdermal Patch Consumption Market Share by Type (2015-2020)
2.5.2 Global Transdermal Patch Value and Market Share by Type (2015-2020)
2.5.3 Global Transdermal Patch Sale Price by Type (2015-2020)
3 Global Transdermal Patch by Company
3.1 Global Transdermal Patch Sales Market Share by Company
3.1.1 Global Transdermal Patch Sales by Company (2018-2020)
3.1.2 Global Transdermal Patch Sales Market Share by Company (2018-2020)
3.2 Global Transdermal Patch Revenue Market Share by Company
3.2.1 Global Transdermal Patch Revenue by Company (2018-2020)
3.2.2 Global Transdermal Patch Revenue Market Share by Company (2018-2020)
3.3 Global Transdermal Patch Sale Price by Company
3.4 Global Transdermal Patch Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Transdermal Patch Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Transdermal Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Transdermal Patch by Regions
4.1 Transdermal Patch by Regions
4.2 Americas Transdermal Patch Consumption Growth
4.3 APAC Transdermal Patch Consumption Growth
4.4 Europe Transdermal Patch Consumption Growth
4.5 Middle East & Africa Transdermal Patch Consumption Growth
5 Americas
5.1 Americas Transdermal Patch Consumption by Countries
5.1.1 Americas Transdermal Patch Consumption by Countries (2015-2020)
5.1.2 Americas Transdermal Patch Value by Countries (2015-2020)
5.2 Americas Transdermal Patch Consumption by Type
5.3 Americas Transdermal Patch Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Transdermal Patch Consumption by Regions
6.1.1 APAC Transdermal Patch Consumption by Regions (2015-2020)
6.1.2 APAC Transdermal Patch Value by Regions (2015-2020)
6.2 APAC Transdermal Patch Consumption by Type
6.3 APAC Transdermal Patch Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Transdermal Patch by Countries
7.1.1 Europe Transdermal Patch Consumption by Countries (2015-2020)
7.1.2 Europe Transdermal Patch Value by Countries (2015-2020)
7.2 Europe Transdermal Patch Consumption by Type
7.3 Europe Transdermal Patch Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Transdermal Patch by Countries
8.1.1 Middle East & Africa Transdermal Patch Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Transdermal Patch Value by Countries (2015-2020)
8.2 Middle East & Africa Transdermal Patch Consumption by Type
8.3 Middle East & Africa Transdermal Patch Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Transdermal Patch Distributors
10.3 Transdermal Patch Customer
11 Global Transdermal Patch Market Forecast
11.1 Global Transdermal Patch Consumption Forecast (2021-2025)
11.2 Global Transdermal Patch Forecast by Regions
11.2.1 Global Transdermal Patch Forecast by Regions (2021-2025)
11.2.2 Global Transdermal Patch Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Transdermal Patch Forecast by Type
11.8 Global Transdermal Patch Forecast by Application
12 Key Players Analysis
12.1 Hisamitsu Pharmaceutical
12.1.1 Company Information
12.1.2 Transdermal Patch Product Offered
12.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Hisamitsu Pharmaceutical Latest Developments
12.2 GSK
12.2.1 Company Information
12.2.2 Transdermal Patch Product Offered
12.2.3 GSK Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 GSK Latest Developments
12.3 Johnson & Johnson
12.3.1 Company Information
12.3.2 Transdermal Patch Product Offered
12.3.3 Johnson & Johnson Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Johnson & Johnson Latest Developments
12.4 UCB Pharma
12.4.1 Company Information
12.4.2 Transdermal Patch Product Offered
12.4.3 UCB Pharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 UCB Pharma Latest Developments
12.5 Mylan
12.5.1 Company Information
12.5.2 Transdermal Patch Product Offered
12.5.3 Mylan Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Mylan Latest Developments
12.6 Novartis
12.6.1 Company Information
12.6.2 Transdermal Patch Product Offered
12.6.3 Novartis Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Novartis Latest Developments
12.7 Grünenthal
12.7.1 Company Information
12.7.2 Transdermal Patch Product Offered
12.7.3 Grünenthal Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Grünenthal Latest Developments
12.8 Teva Pharmaceutical
12.8.1 Company Information
12.8.2 Transdermal Patch Product Offered
12.8.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Teva Pharmaceutical Latest Developments
12.9 IBSA Group
12.9.1 Company Information
12.9.2 Transdermal Patch Product Offered
12.9.3 IBSA Group Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 IBSA Group Latest Developments
12.10 Nitto Denko
12.10.1 Company Information
12.10.2 Transdermal Patch Product Offered
12.10.3 Nitto Denko Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Nitto Denko Latest Developments
12.11 Mundipharma
12.11.1 Company Information
12.11.2 Transdermal Patch Product Offered
12.11.3 Mundipharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Mundipharma Latest Developments
12.12 Beijing Tide Pharmaceutical
12.12.1 Company Information
12.12.2 Transdermal Patch Product Offered
12.12.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Beijing Tide Pharmaceutical Latest Developments
12.13 Endo International
12.13.1 Company Information
12.13.2 Transdermal Patch Product Offered
12.13.3 Endo International Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Endo International Latest Developments
12.14 Luye Pharma Group
12.14.1 Company Information
12.14.2 Transdermal Patch Product Offered
12.14.3 Luye Pharma Group Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Luye Pharma Group Latest Developments
12.15 Dr Reddy's Laboratories
12.15.1 Company Information
12.15.2 Transdermal Patch Product Offered
12.15.3 Dr Reddy's Laboratories Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Dr Reddy's Laboratories Latest Developments
12.16 Chattem
12.16.1 Company Information
12.16.2 Transdermal Patch Product Offered
12.16.3 Chattem Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Chattem Latest Developments
12.17 Bayer
12.17.1 Company Information
12.17.2 Transdermal Patch Product Offered
12.17.3 Bayer Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Bayer Latest Developments
12.18 Pfizer
12.18.1 Company Information
12.18.2 Transdermal Patch Product Offered
12.18.3 Pfizer Transdermal Patch Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Pfizer Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Transdermal Patch Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Methyl Salicylate-Based Patch
Table 5. Major Players of Rivastigmine Transdermal Patch
Table 6. Major Players of Fentanyl Transdermal Patch
Table 7. Major Players of Lidocaine Patch
Table 8. Major Players of Diclofenac Patch
Table 9. Major Players of Nicotine Transdermal Patch
Table 10. Major Players of Others
Table 11. Global Consumption Sales by Type (2015-2020)
Table 12. Global Transdermal Patch Consumption Market Share by Type (2015-2020)
Table 13. Global Transdermal Patch Revenue by Type (2015-2020) ($ million)
Table 14. Global Transdermal Patch Value Market Share by Type (2015-2020) ($ Millions)
Table 15. Global Transdermal Patch Sale Price by Type (2015-2020)
Table 16. Global Consumption Sales by Application (2015-2020)
Table 17. Global Transdermal Patch Consumption Market Share by Application (2015-2020)
Table 18. Global Transdermal Patch Value by Application (2015-2020)
Table 19. Global Transdermal Patch Value Market Share by Application (2015-2020)
Table 20. Global Transdermal Patch Sale Price by Application (2015-2020)
Table 21. Global Transdermal Patch Sales by Company (2017-2019) (M Pcs)
Table 22. Global Transdermal Patch Sales Market Share by Company (2017-2019)
Table 23. Global Transdermal Patch Revenue by Company (2017-2019) ($ Millions)
Table 24. Global Transdermal Patch Revenue Market Share by Company (2017-2019)
Table 25. Global Transdermal Patch Sale Price by Company (2017-2019)
Table 26. Global Transdermal Patch Manufacturing Base Distribution and Sales Area by Manufacturers
Table 27. Players Transdermal Patch Products Offered
Table 28. Transdermal Patch Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 29. Global Transdermal Patch Consumption by Regions 2015-2020 (M Pcs)
Table 30. Global Transdermal Patch Consumption Market Share by Regions 2015-2020
Table 31. Global Transdermal Patch Value by Regions 2015-2020 ($ Millions)
Table 32. Global Transdermal Patch Value Market Share by Regions 2015-2020
Table 33. Americas Transdermal Patch Consumption by Countries (2015-2020) (M Pcs)
Table 34. Americas Transdermal Patch Consumption Market Share by Countries (2015-2020)
Table 35. Americas Transdermal Patch Value by Countries (2015-2020) ($ Millions)
Table 36. Americas Transdermal Patch Value Market Share by Countries (2015-2020)
Table 37. Americas Transdermal Patch Consumption by Type (2015-2020) (M Pcs)
Table 38. Americas Transdermal Patch Consumption Market Share by Type (2015-2020)
Table 39. Americas Transdermal Patch Consumption by Application (2015-2020) (M Pcs)
Table 40. Americas Transdermal Patch Consumption Market Share by Application (2015-2020)
Table 41. APAC Transdermal Patch Consumption by Regions (2015-2020) (M Pcs)
Table 42. APAC Transdermal Patch Consumption Market Share by Regions (2015-2020)
Table 43. APAC Transdermal Patch Value by Regions (2015-2020) ($ Millions)
Table 44. APAC Transdermal Patch Value Market Share by Regions (2015-2020)
Table 45. APAC Transdermal Patch Consumption by Type (2015-2020) (M Pcs)
Table 46. APAC Transdermal Patch Consumption Market Share by Type (2015-2020)
Table 47. APAC Transdermal Patch Consumption by Application (2015-2020) (M Pcs)
Table 48. APAC Transdermal Patch Consumption Market Share by Application (2015-2020)
Table 49. Europe Transdermal Patch Consumption by Countries (2015-2020) (M Pcs)
Table 50. Europe Transdermal Patch Consumption Market Share by Countries (2015-2020)
Table 51. Europe Transdermal Patch Value by Countries (2015-2020) ($ Millions)
Table 52. Europe Transdermal Patch Value Market Share by Countries (2015-2020)
Table 53. Europe Transdermal Patch Consumption by Type (2015-2020) (M Pcs)
Table 54. Europe Transdermal Patch Consumption Market Share by Type (2015-2020)
Table 55. Europe Transdermal Patch Consumption by Application (2015-2020) (M Pcs)
Table 56. Europe Transdermal Patch Consumption Market Share by Application (2015-2020)
Table 57. Middle East & Africa Transdermal Patch Consumption by Countries (2015-2020) (M Pcs)
Table 58. Middle East & Africa Transdermal Patch Consumption Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Transdermal Patch Value by Countries (2015-2020) ($ Millions)
Table 60. Middle East & Africa Transdermal Patch Value Market Share by Countries (2015-2020)
Table 61. Middle East & Africa Transdermal Patch Consumption by Type (2015-2020) (M Pcs)
Table 62. Middle East & Africa Transdermal Patch Consumption Market Share by Type (2015-2020)
Table 63. Middle East & Africa Transdermal Patch Consumption by Application (2015-2020) (M Pcs)
Table 64. Middle East & Africa Transdermal Patch Consumption Market Share by Application (2015-2020)
Table 65. Transdermal Patch Distributors List
Table 66. Transdermal Patch Customer List
Table 67. Global Transdermal Patch Consumption Forecast by Countries (2021-2025) (M Pcs)
Table 68. Global Transdermal Patch Consumption Market Forecast by Regions
Table 69. Global Transdermal Patch Value Forecast by Countries (2021-2025) ($ Millions)
Table 70. Global Transdermal Patch Value Market Share Forecast by Regions
Table 71. Global Transdermal Patch Consumption Forecast by Type (2021-2025) (M Pcs)
Table 72. Global Transdermal Patch Consumption Market Share Forecast by Type (2021-2025)
Table 73. Global Transdermal Patch Value Forecast by Type (2021-2025) ($ Millions)
Table 74. Global Transdermal Patch Value Market Share Forecast by Type (2021-2025)
Table 75. Global Transdermal Patch Consumption Forecast by Application (2021-2025) (M Pcs)
Table 76. Global Transdermal Patch Consumption Market Share Forecast by Application (2021-2025)
Table 77. Global Transdermal Patch Value Forecast by Application (2021-2025) ($ Millions)
Table 78. Global Transdermal Patch Value Market Share Forecast by Application (2021-2025)
Table 79. Hisamitsu Pharmaceutical Product Offered
Table 80. Hisamitsu Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/Pc) and Gross Margin (2018-2020E)
Table 81. Hisamitsu Pharmaceutical Main Business
Table 82. Hisamitsu Pharmaceutical Latest Developments
Table 83. Hisamitsu Pharmaceutical Basic Information, Company Total Revenue (in $ million), Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 84. GSK Product Offered
Table 85. GSK Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/Pc) and Gross Margin (2018-2020E)
Table 86. GSK Main Business
Table 87. GSK Latest Developments
Table 88. GSK Basic Information, Company Total Revenue (in $ million), Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 89. Johnson & Johnson Product Offered
Table 90. Johnson & Johnson Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/Pc) and Gross Margin (2018-2020E)
Table 91. Johnson & Johnson Main Business
Table 92. Johnson & Johnson Latest Developments
Table 93. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 94. UCB Pharma Product Offered
Table 95. UCB Pharma Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/Pc) and Gross Margin (2018-2020E)
Table 96. UCB Pharma Main Business
Table 97. UCB Pharma Latest Developments
Table 98. UCB Pharma Basic Information, Company Total Revenue (in $ million), Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 99. Mylan Product Offered
Table 100. Mylan Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/Pc) and Gross Margin (2018-2020E)
Table 101. Mylan Main Business
Table 102. Mylan Latest Developments
Table 103. Mylan Basic Information, Company Total Revenue (in $ million), Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 104. Novartis Product Offered
Table 105. Novartis Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/Pc) and Gross Margin (2018-2020E)
Table 106. Novartis Main Business
Table 107. Novartis Latest Developments
Table 108. Novartis Basic Information, Company Total Revenue (in $ million), Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 109. Grünenthal Product Offered
Table 110. Grünenthal Basic Information, Company Total Revenue (in $ million), Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 111. Grünenthal Main Business
Table 112. Grünenthal Latest Developments
Table 113. Grünenthal Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/Pc) and Gross Margin (2018-2020E)
Table 114. Teva Pharmaceutical Product Offered
Table 115. Teva Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/Pc) and Gross Margin (2018-2020E)
Table 116. Teva Pharmaceutical Main Business
Table 117. Teva Pharmaceutical Latest Developments
Table 118. Teva Pharmaceutical Basic Information, Company Total Revenue (in $ million), Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 119. IBSA Group Product Offered
Table 120. IBSA Group Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/Pc) and Gross Margin (2018-2020E)
Table 121. IBSA Group Main Business
Table 122. IBSA Group Latest Developments
Table 123. IBSA Group Basic Information, Company Total Revenue (in $ million), Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 124. Nitto Denko Product Offered
Table 125. Nitto Denko Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/Pc) and Gross Margin (2018-2020E)
Table 126. Nitto Denko Main Business
Table 127. Nitto Denko Latest Developments
Table 128. Nitto Denko Basic Information, Company Total Revenue (in $ million), Transdermal Patch Manufacturing Base, Sales Area and Its Competitors
Table 129. Mundipharma Product Offered
Table 130. Mundipharma Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/Pc) and Gross Margin (2018-2020E)
Table 131. Mundipharma Main Business
Table 132. Mundipharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Mundipharma Latest Developments
Table 134. Beijing Tide Pharmaceutical Product Offered
Table 135. Beijing Tide Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/Pc) and Gross Margin (2018-2020E)
Table 136. Beijing Tide Pharmaceutical Main Business
Table 137. Beijing Tide Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 138. Beijing Tide Pharmaceutical Latest Developments
Table 139. Endo International Product Offered
Table 140. Endo International Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/Pc) and Gross Margin (2018-2020E)
Table 141. Endo International Main Business
Table 142. Endo International Latest Developments
Table 143. Endo International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. Luye Pharma Group Product Offered
Table 145. Luye Pharma Group Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/Pc) and Gross Margin (2018-2020E)
Table 146. Luye Pharma Group Main Business
Table 147. Luye Pharma Group Latest Developments
Table 148. Luye Pharma Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 149. Dr Reddy's Laboratories Product Offered
Table 150. Dr Reddy's Laboratories Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/Pc) and Gross Margin (2018-2020E)
Table 151. Dr Reddy's Laboratories Main Business
Table 152. Dr Reddy's Laboratories Latest Developments
Table 153. Dr Reddy's Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 154. Chattem Product Offered
Table 155. Chattem Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/Pc) and Gross Margin (2018-2020E)
Table 156. Chattem Main Business
Table 157. Chattem Latest Developments
Table 158. Chattem Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 159. Bayer Product Offered
Table 160. Bayer Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/Pc) and Gross Margin (2018-2020E)
Table 161. Bayer Main Business
Table 162. Bayer Latest Developments
Table 163. Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 164. Pfizer Product Offered
Table 165. Pfizer Transdermal Patch Sales (M Pcs), Revenue ($ Million), Price (USD/Pc) and Gross Margin (2018-2020E)
Table 166. Pfizer Main Business
Table 167. Pfizer Latest Developments
Table 168. Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Transdermal Patch
Figure 2. Transdermal Patch Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Transdermal Patch Consumption Growth Rate 2015-2025 (M Pcs)
Figure 5. Global Transdermal Patch Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Methyl Salicylate-Based Patch
Figure 7. Product Picture of Rivastigmine Transdermal Patch
Figure 8. Product Picture of Fentanyl Transdermal Patch
Figure 9. Product Picture of Lidocaine Patch
Figure 10. Product Picture of Diclofenac Patch
Figure 11. Product Picture of Nicotine Transdermal Patch
Figure 12. Product Picture of Others
Figure 13. Global Transdermal Patch Consumption Market Share by Type (2015-2020)
Figure 14. Global Transdermal Patch Value Market Share by Type (2015-2020)
Figure 15. Transdermal Patch Consumed in Rx Channel
Figure 16. Global Transdermal Patch Market: Rx Channel (2015-2020) (M Pcs)
Figure 17. Global Transdermal Patch Market: Rx Channel (2015-2020) ($ Millions)
Figure 18. Transdermal Patch Consumed in OTC Channel
Figure 19. Global Transdermal Patch Market: OTC Channel (2015-2020) (M Pcs)
Figure 20. Global Transdermal Patch Market: OTC Channel (2015-2020) ($ Millions)
Figure 21. Global Transdermal Patch Consumption Market Share by Application (2015-2020)
Figure 22. Global Transdermal Patch Value Market Share by Application (2015-2020)
Figure 23. Global Transdermal Patch Sales Market Share by Company in 2017
Figure 24. Global Transdermal Patch Sales Market Share by Company in 2019
Figure 25. Global Transdermal Patch Revenue Market Share by Company in 2017
Figure 26. Global Transdermal Patch Revenue Market Share by Company in 2019
Figure 27. Global Transdermal Patch Sale Price by Company in 2019
Figure 28. Global Transdermal Patch Consumption Market Share by Regions 2015-2020
Figure 29. Global Transdermal Patch Value Market Share by Regions 2015-2020
Figure 30. Americas Transdermal Patch Consumption 2015-2020 (M Pcs)
Figure 31. Americas Transdermal Patch Value 2015-2020 ($ Millions)
Figure 32. APAC Transdermal Patch Consumption 2015-2020 (M Pcs)
Figure 33. APAC Transdermal Patch Value 2015-2020 ($ Millions)
Figure 34. Europe Transdermal Patch Consumption 2015-2020 (M Pcs)
Figure 35. Europe Transdermal Patch Value 2015-2020 ($ Millions)
Figure 36. Middle East & Africa Transdermal Patch Consumption 2015-2020 (M Pcs)
Figure 37. Middle East & Africa Transdermal Patch Value 2015-2020 ($ Millions)
Figure 38. Americas Transdermal Patch Consumption Market Share by Countries in 2019
Figure 39. Americas Transdermal Patch Value Market Share by Countries in 2019
Figure 40. Americas Transdermal Patch Consumption Market Share by Type in 2019
Figure 41. Americas Transdermal Patch Consumption Market Share by Application in 2019
Figure 42. United States Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 43. United States Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 44. Canada Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 45. Canada Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 46. Mexico Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 47. Mexico Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 48. APAC Transdermal Patch Consumption Market Share by Countries in 2019
Figure 49. APAC Transdermal Patch Value Market Share by Regions in 2019
Figure 50. APAC Transdermal Patch Consumption Market Share by Type in 2019
Figure 51. APAC Transdermal Patch Consumption Market Share by Application in 2019
Figure 52. China Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 53. China Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 54. Japan Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 55. Japan Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 56. Korea Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 57. Korea Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 58. Southeast Asia Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 59. Southeast Asia Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 60. India Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 61. India Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 62. Australia Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 63. Australia Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 64. Europe Transdermal Patch Consumption Market Share by Countries in 2019
Figure 65. Europe Transdermal Patch Value Market Share by Countries in 2019
Figure 66. Europe Transdermal Patch Consumption Market Share by Type in 2019
Figure 67. Europe Transdermal Patch Consumption Market Share by Application in 2019
Figure 68. Germany Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 69. Germany Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 70. France Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 71. France Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 72. UK Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 73. UK Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 74. Italy Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 75. Italy Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 76. Russia Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 77. Russia Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Transdermal Patch Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Transdermal Patch Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Transdermal Patch Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Transdermal Patch Consumption Market Share by Application in 2019
Figure 82. Egypt Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 83. Egypt Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 85. South Africa Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 87. Israel Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 89. Turkey Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Transdermal Patch Consumption Growth 2015-2020 (M Pcs)
Figure 91. GCC Countries Transdermal Patch Value Growth 2015-2020 ($ Millions)
Figure 92. Global Transdermal Patch Consumption Growth Rate Forecast (2021-2025) (M Pcs)
Figure 93. Global Transdermal Patch Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 95. Americas Transdermal Patch Value 2021-2025 ($ Millions)
Figure 96. APAC Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 97. APAC Transdermal Patch Value 2021-2025 ($ Millions)
Figure 98. Europe Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 99. Europe Transdermal Patch Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 101. Middle East & Africa Transdermal Patch Value 2021-2025 ($ Millions)
Figure 102. United States Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 103. United States Transdermal Patch Value 2021-2025 ($ Millions)
Figure 104. Canada Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 105. Canada Transdermal Patch Value 2021-2025 ($ Millions)
Figure 106. Mexico Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 107. Mexico Transdermal Patch Value 2021-2025 ($ Millions)
Figure 108. Brazil Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 109. Brazil Transdermal Patch Value 2021-2025 ($ Millions)
Figure 110. China Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 111. China Transdermal Patch Value 2021-2025 ($ Millions)
Figure 112. Japan Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 113. Japan Transdermal Patch Value 2021-2025 ($ Millions)
Figure 114. Korea Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 115. Korea Transdermal Patch Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 117. Southeast Asia Transdermal Patch Value 2021-2025 ($ Millions)
Figure 118. India Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 119. India Transdermal Patch Value 2021-2025 ($ Millions)
Figure 120. Australia Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 121. Australia Transdermal Patch Value 2021-2025 ($ Millions)
Figure 122. Germany Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 123. Germany Transdermal Patch Value 2021-2025 ($ Millions)
Figure 124. France Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 125. France Transdermal Patch Value 2021-2025 ($ Millions)
Figure 126. UK Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 127. UK Transdermal Patch Value 2021-2025 ($ Millions)
Figure 128. Italy Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 129. Italy Transdermal Patch Value 2021-2025 ($ Millions)
Figure 130. Russia Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 131. Russia Transdermal Patch Value 2021-2025 ($ Millions)
Figure 132. Spain Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 133. Spain Transdermal Patch Value 2021-2025 ($ Millions)
Figure 134. Egypt Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 135. Egypt Transdermal Patch Value 2021-2025 ($ Millions)
Figure 136. South Africa Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 137. South Africa Transdermal Patch Value 2021-2025 ($ Millions)
Figure 138. Israel Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 139. Israel Transdermal Patch Value 2021-2025 ($ Millions)
Figure 140. Turkey Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 141. Turkey Transdermal Patch Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Transdermal Patch Consumption 2021-2025 (M Pcs)
Figure 143. GCC Countries Transdermal Patch Value 2021-2025 ($ Millions)
Figure 144. Hisamitsu Pharmaceutical Transdermal Patch Market Share (2018-2020)
Figure 145. GSK Transdermal Patch Market Share (2018-2020)
Figure 146. Johnson & Johnson Transdermal Patch Market Share (2018-2020)
Figure 147. UCB Pharma Transdermal Patch Market Share (2018-2020)
Figure 148. Mylan Transdermal Patch Market Share (2018-2020)
Figure 149. Novartis Transdermal Patch Market Share (2018-2020)
Figure 150. Grünenthal Transdermal Patch Market Share (2018-2020)
Figure 151. Teva Pharmaceutical Transdermal Patch Market Share (2018-2020)
Figure 152. IBSA Group Transdermal Patch Market Share (2018-2020)
Figure 153. Nitto Denko Transdermal Patch Market Share (2018-2020)
Figure 154. Mundipharma Transdermal Patch Market Share (2018-2020)
Figure 155. Beijing Tide Pharmaceutical Transdermal Patch Market Share (2018-2020)
Figure 156. Endo International Transdermal Patch Market Share (2018-2020)
Figure 157. Luye Pharma Group Transdermal Patch Market Share (2018-2020)
Figure 158. Dr Reddy's Laboratories Transdermal Patch Market Share (2018-2020)
Figure 159. Chattem Transdermal Patch Market Share (2018-2020)
Figure 160. Bayer Transdermal Patch Market Share (2018-2020)
Figure 161. Pfizer Transdermal Patch Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets